BSE Live
Apr 21, 16:01Prev. Close
172.75
Open Price
173.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Sanjivani Parenteral (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 69.56 | 53.69 | 35.24 | 30.38 | 25.10 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 69.56 | 53.69 | 35.24 | 30.38 | 25.10 | |
| Total Operating Revenues | 70.10 | 54.41 | 35.49 | 30.61 | 25.10 | |
| Other Income | 1.21 | 0.52 | 0.55 | 0.24 | 0.26 | |
| Total Revenue | 71.31 | 54.93 | 36.05 | 30.86 | 25.36 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 33.56 | 34.37 | 19.84 | 12.66 | 14.14 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 3.91 | 4.32 | 3.30 | 2.94 | 1.83 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 6.92 | -5.89 | -1.28 | -0.35 | 0.67 | |
| Employee Benefit Expenses | 6.49 | 4.10 | 3.27 | 3.09 | 2.49 | |
| Finance Costs | 0.59 | 0.25 | 0.36 | 0.21 | 0.13 | |
| Depreciation And Amortisation Expenses | 0.62 | 0.93 | 0.89 | 0.88 | 0.86 | |
| Other Expenses | 8.85 | 9.27 | 4.72 | 6.56 | 3.83 | |
| Total Expenses | 60.95 | 47.36 | 31.10 | 25.98 | 23.95 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 10.36 | 7.57 | 4.94 | 4.88 | 1.41 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 10.36 | 7.57 | 4.94 | 4.88 | 1.41 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 1.84 | 1.35 | 0.81 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.41 | 0.05 | -0.61 | 0.03 | 0.00 | |
| Tax For Earlier Years | 0.01 | 0.01 | 0.23 | 0.00 | -0.01 | |
| Total Tax Expenses | 2.26 | 1.41 | 0.43 | 0.03 | -0.01 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 8.10 | 6.17 | 4.51 | 4.85 | 1.42 | |
| Profit/Loss From Continuing Operations | 8.10 | 6.17 | 4.51 | 4.85 | 1.42 | |
| Profit/Loss For The Period | 8.10 | 6.17 | 4.51 | 4.85 | 1.42 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 6.89 | 5.28 | 4.51 | 4.85 | 1.67 | |
| Diluted EPS (Rs.) | 6.67 | 5.28 | 4.51 | 4.85 | 1.67 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 5.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.11.2025
Sanjivani Paren Consolidated September 2025 Net Sales at Rs 18.50 crore, up 2.02% Y-o-Y
24.11.2025
Sanjivani Paren Standalone September 2025 Net Sales at Rs 15.50 crore, down 14.53% Y-o-Y
09.09.2025
Sanjivani Paren Standalone June 2025 Net Sales at Rs 17.89 crore, up 8.85% Y-o-Y
03.06.2025
Sanjivani Paren Consolidated March 2025 Net Sales at Rs 18.18 crore, up 41.33% Y-o-Y
26.11.2025
Sanjivani Paren Consolidated September 2025 Net Sales at Rs 18.50 crore, up 2.02% Y-o-Y
24.11.2025
Sanjivani Paren Standalone September 2025 Net Sales at Rs 15.50 crore, down 14.53% Y-o-Y
09.09.2025
Sanjivani Paren Standalone June 2025 Net Sales at Rs 17.89 crore, up 8.85% Y-o-Y
03.06.2025
Sanjivani Paren Consolidated March 2025 Net Sales at Rs 18.18 crore, up 41.33% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth